EVH Evolent Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: EVH

Price (delayed)

$29.26

Market cap

$3.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.28

Enterprise value

$3.83B

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
The revenue has grown by 45% YoY and by 10% from the previous quarter
EVH's gross profit is up by 45% year-on-year and by 4.2% since the previous quarter
The company's equity rose by 24% YoY but it fell by 2.6% QoQ
The debt has increased by 35% YoY
The EPS fell by 25% QoQ
Sector: Healthcare
Industry: Health Information Services
Website: http://www.evolenthealth.com
Peers: NHC GHC ARMK NVEE

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
115.43M
Market cap
$3.38B
Enterprise value
$3.83B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.15
Price to sales (P/S)
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.95
Earnings
Revenue
$1.96B
EBIT
-$148.2M
EBITDA
-$24.79M
Free cash flow
$113.84M
Per share
EPS
-$1.28
Free cash flow per share
$1.02
Book value per share
$9.29
Revenue per share
$17.65
TBVPS
$7.3
Balance sheet
Total assets
$2.68B
Total liabilities
$1.43B
Debt
$644.8M
Equity
$1.07B
Working capital
$9.43M
Liquidity
Debt to equity
0.6
Current ratio
1.01
Quick ratio
0.97
Net debt/EBITDA
-18.24
Margins
EBITDA margin
-1.3%
Gross margin
23.4%
Net margin
-5.8%
Operating margin
-2.7%
Efficiency
Return on assets
-5.4%
Return on equity
-13%
Return on invested capital
-22.1%
Return on capital employed
-7.4%
Return on sales
-7.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
-2.89%
1 week
-1.28%
1 month
-9.75%
1 year
-17.25%
YTD
-11.41%
QTD
-10.77%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$1.96B
Gross profit
$460.47M
Operating income
-$53.23M
Net income
-$113.04M
Gross margin
23.4%
Net margin
-5.8%
The company's operating income has shrunk by 168% YoY but it rose by 7% QoQ
The operating margin has plunged by 80% YoY but it has increased by 16% from the previous quarter
The revenue has grown by 45% YoY and by 10% from the previous quarter
EVH's gross profit is up by 45% year-on-year and by 4.2% since the previous quarter

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
3.15
P/S
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.95
The EPS fell by 25% QoQ
The company's equity rose by 24% YoY but it fell by 2.6% QoQ
EVH's price to book (P/B) is 17% higher than its 5-year quarterly average of 2.7
The revenue has grown by 45% YoY and by 10% from the previous quarter
The price to sales (P/S) is 17% lower than the last 4 quarters average of 2.0 and 8% lower than the 5-year quarterly average of 1.8

Efficiency

How efficient is Evolent Health business performance
EVH's return on invested capital has dropped by 117% year-on-year and by 16% since the previous quarter
The ROS has shrunk by 114% YoY and by 9% QoQ
The ROE has contracted by 20% from the previous quarter
Evolent Health's return on assets has decreased by 17% QoQ

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 87% higher than its total liabilities
The total liabilities has increased by 50% YoY and by 2.6% from the previous quarter
The company's total assets rose by 47% YoY
The debt is 40% lower than the equity
The debt has increased by 35% YoY
The company's equity rose by 24% YoY but it fell by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.